Glyphosate Facts

Transparency on safety aspects and use of glyphosate-containing herbicides in Europe


GTF proposes access to all 14 carcinogenicity studies via reading rooms

In order to help address public concerns regarding the safety of glyphosate products, and without, in any way setting a precedent for other studies and substances, the GTF proposed on April 4 in a letter to Commissioner Andriukaitis to voluntarily provide access through a physical reading room (or rooms) and on an exceptional basis to copies of all 14 carcinogenicity studies submitted by the GTF. This includes the studies referred to by Commissioner Andriukaitis’ in his letter of April 4th 2016.

All 14 studies have already been published as part of a peer-reviewed scientific article and can be accessed online (Greim et al. Critical Reviews in Toxicology Volume 45,  Issue 3, 2015).

As part of the approval process for active substances, industry is obliged to generate data which is then evaluated alongside other sources of information such as open (published) studies. The admissibility of industry studies is dependent on adherence to rigorous standards, such as OECD guidelines on Good Laboratory Practice (GLP).

The GTF wishes to highlight that the debate about glyphosate and questions of confidentiality of data submitted by industry according to the applicable regulatory framework must not be used to undermine the whole basis for the evaluation of plant protection products as set out in EU legislation.

Last update: 11 April 2016